
Eisai and Merck & Co., Inc., Rahway, NJ, USA Provide Update on Phase 3 LEAP012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma
TOKYO and RAHWAY, NJ, Oct. 29, […]

HIROSHIMA, Japan, October 29, […]

HIROSHIMA, Japan, October 29, […]

TOKYO, Japan, October 29, 2025 […]

TOKYO, Japan, October 29, 2025 […]

Booth Image TOKYO, October 28, […]
The signing of the MoU between […]

TOKYO, October 28, 2025 – […]

TOKYO, Japan, October 27, 2025 […]

Saudi Arabia, Oct 27, 2025  […]

TOKYO and CAMBRIDGE, Mass., Oc […]

Lausanne, Switzerland, Kawasak […]

TOKYO, October 24, 2025 – […]

Toyota City, Japan, October 23 […]

From left (seated): Daichi Nak […]

TOKYO, Japan, October 22, 2025 […]

KAWASAKI, Japan, October 22, 2 […]

THUNDERBEAT™ II features […]
TOKYO, October 21, 2025 – […]
TOKYO, Japan, October 21, 2025 […]

BANDUNG, INDONESIA, Oct 21, 20 […]